Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing (Q57208602)
Jump to navigation
Jump to search
scientific article published on 01 September 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing |
scientific article published on 01 September 1994 |
Statements
Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing (English)
H Suzuki
S Iino
K Shiraki
Y Akahane
1 September 1994